Year: 2020

JINHUA, China, Nov. 10, 2020 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company” or “Kandi”) (NASDAQ GS: KNDI), today announced that it has entered into a securities purchase agreement with certain institutional investors for a registered direct placement of $60 million of common stock at a price of $6.38 per share. The Company will issue a total of 9,404,392 shares of common stock to the institutional investors. As part of the transaction, the Company will also issue to the investors warrants (“Warrants”) for the purchase of up to 3,761,756 shares of common stock at an exercise price of $8.18 per share, which Warrants will have a term of 30 months from the date of issuance but are not exercisable for the first six months. The net proceeds from this offering will be used for general working corporate purposes.  The completion...

San Juan, PUERTO RICO, Nov. 10, 2020 (GLOBE NEWSWIRE) — BOTS, Inc. (OTC: BTZI), an emerging innovator of products, technologies, and services for the rapidly growing cyber-security, digital robotics automation and AI for manufacturing industries announced they are partnering with Cyber Security Group to introduce a new Web Application Firewall (WAF) (https://bots.cybsecgroup.com/)This real-time solution provides complete protection against both bots-based (DDoS) and application, API, user, or infrastructure threats.WAF from Bots/CSG is a comprehensive, layered protection stack that proactively prevents bot-based volumetric attacks, as well as threats that target the application layer, such as SQL, XSS, CSRF, session hijacking, data exfiltration and zero-day vulnerabilities.Paul Rosenberg, CEO of Bots Inc. stated: “Even though...

WICHITA, Kan., Nov. 10, 2020 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE American: UAVS), an industry leading provider of unmanned aerial vehicles and advanced aerial imagery, data collection and analytics technologies, today announced its selection as an industry partner in the next phase of the U.S. Department of Transportation’s (U.S. DOT) Unmanned Aircraft System Integration Pilot Program (IPP), the BEYOND program.The original IPP was launched through a Presidential Memorandum in October 2017 with nine regional participants. The IPP participants and their industry partners used innovative strategies to craft successful safety cases to operate under the Federal Aviation Administration’s (FAA) existing regulations. On October 30, 2020, the U.S. DOT announced that the three-year IPP successfully concluded on October 25,...

BASKING RIDGE, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, announces its presentation at American Heart Association’s (“AHA”) Scientific Sessions, being held virtually November 13-17, 2020.AHA Virtual Scientific Sessions 2020Note: This session is OnDemand and will be available via AHA Scientific Session’s virtual platform on November 13, 2020 at 9:00 a.m. (CST) until November 17, 2020 at 8:30 p.m. (CST).Evidence from research by others indicates that severe cases of COVID-19 are accompanied by damage to the pulmonary endothelium.1,2 These data indicate SARS-CoV2 is particularly avid for the lung microvascular endothelium, destroying microvascular...

EDISON, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) — StrikeForce Technologies, Inc. (OTC PINK: SFOR), is pleased to provide a shareholder update with accomplishments achieved to date, in a most challenging year due to the Covid-19 pandemic.Midway through the 4th qtr., will prove to be a turning point in the Company’s future, the SEC is close to granting initial qualification of the Company’s Reg A Tier II registration statement, secured by Continuation Capital, Inc. as an anchor investor for the Reg A. StrikeForce has also reached agreements with convertible note holders for cash settlements.StrikeForce initially filed the Reg A Tier II in July, and successfully completed two rounds of comments with the SEC and currently FINRA is completing their review process. The Company anticipates initial funding to be received in the coming days....

Seattle, WA, Nov. 10, 2020 (GLOBE NEWSWIRE) — via NewMediaWire —  ReelTime VR/ReelTime Media (OTC:RLTR) has formally submitted an application as a Seasoned Company Seeking to Transfer Equity and/or Debt Securities from Another U.S. Exchange to be listed on the NASDAQ Capital Market Exchange. The application has been logged in the NASDAQ Listing Center, all applicable fees have been paid, and a listing analyst has been assigned to ReelTime to assist throughout the process. In addition, the request for a new symbol to be reserved for ReelTime to trade under once the Company has met all quantitative and qualitative criteria, including certain corporate governance requirements has been approved.The Company expects to announce the new symbol this week.ReelTime will continue to submit additional information and documentation as...

LA JOLLA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that Bruce Steel, Equillium’s chief executive officer and Krishna Polu, M.D., Equillium’s chief medical officer, will present at two upcoming investor conferences in November 2020.Live webcasts of both presentations will be available under the “Investors” section of the Company’s website at https://ir.equilliumbio.com/. Replays will be available for 30 days following each webcast.About ItolizumabItolizumab is a clinical-stage, first-in-class monoclonal antibody that selectively targets the CD6-ALCAM pathway. This pathway plays a central role in modulating the activity and trafficking of T cells that drive a number of immuno-inflammatory...